Navigation Links
Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
Date:11/2/2009

PRINCETON, N.J., Nov. 2 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Jeffrey Trotter has joined the Company as Executive Vice President, Phase IV Development. In his role, he will provide leadership for the Company's Phase IV operations and its global expansion.

"We are very pleased to have Jeff Trotter join PharmaNet," commented Jeffrey P. McMullen, president and chief executive officer. "His depth of experience and pioneering approaches to patient registries, health economics and outcomes research will enable us to expand our services to clients seeking to undertake the full range of peri-approval research programs."

Mr. McMullen continued, "Phase IV services continue to be a growth opportunity for PharmaNet. I am confident we can strengthen our presence to become the definitive choice for research excellence in this critical and rapidly changing field."

As an entrepreneur, researcher, consultant and industry leader, Jeffrey Trotter has been an innovator in the evolving outcomes research community, most recently providing strategic and operational direction to pharmaceutical and device companies on the importance of 'real world' clinical research, observational studies and patient registries. Mr. Trotter was founder and president of Ovation Research Group, one of the leading independent research and consulting organizations providing health economics and outcomes research for pharmaceutical and medical device companies. Ovation became known worldwide for its industry-leading perspectives on patient registries, clinical studies fulfilling a broad continuum of needs ranging from product commercialization to safety surveillance and risk management. Having sold Ovation, Jeff joins PharmaNet Development Group from his independent consultancy, J. Trotter Research and Consulting.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 43 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    Email: ahess@pharmanet.com

SOURCE PharmaNet Development Group


'/>"/>
SOURCE PharmaNet Development Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
2. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
3. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
4. Marsha Fanucci Joins Ironwood Board of Directors
5. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
6. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
7. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
8. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
9. UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
10. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
11. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Research and Markets has announced the addition of the "Global ... - Forecast to 2025" report to their offering. ... , , ... a CAGR of around 3.2% from 2015 to 2025. Some of ... extracellular microelectrode arrays and intracellular microelectrodes, research in left-to-right shunt detection ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... PITTSBURGH, PA (PRWEB) , ... December 09, 2016 , ... ... would permit amputees to safely ride all types of amusement park rides. , The ... Additionally, the unit is easy to use and could be set up in a ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pennsylvania Cable Network (PCN) during the summer of 2016. The program was made ... by the United States Department of Health and Human Services Administration. The ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a ... and Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative ... of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , Ginger ... Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport ... attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured ...
(Date:12/8/2016)... ... ... STATEN ISLAND, N.Y., Nov. 24, 2016 — Richmond ... of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services from three ... , Among the recognitions, the American College of Surgeons' (ACS) named the hospital's ...
Breaking Medicine News(10 mins):